title: Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial.
abstract: BACKGROUND
  Although the effects of D: -cycloserine (DCS) and valproic acid (VPA) on the facilitation of the extinction of fear-conditioned memory have been elucidated in animals, these effects have not been clearly confirmed in humans.
  
  
  OBJECTIVE
  This study aimed to determine the effect of DCS (100 mg) and VPA (400 mg) on the facilitation of the extinction and acquisition of fear-conditioned memory in humans.
  
  
  METHODS
  We performed a randomized, blind, placebo-controlled, four-arm clinical trial in 60 healthy adults. Visual cues and electric shocks were used as the conditioned stimulus (CS) and unconditioned stimulus (US), respectively.
  
  
  RESULTS
  The extinction or acquisition effect was not observed in the simple recall after the extinction or acquisition of coupled CS-US; however, the extinction and habituation effects but not the acquisition effects were presented after the unexpected re-exposure of coupled CS-US (reinstatement stimuli). Extinction and habituation effects were facilitated by either a single dose of DCS or VPA or a combination of DCS and VPA. However, we did not observe the expected synergistic effect of the combined treatment on the extinction or habituation of fear conditioning.
  
  
  CONCLUSIONS
  A single dose of DCS or VPA might enhance exposure-based cognitive therapy of anxiety disorders by reducing the vulnerability to reinstatement and preventing relapses of fear-conditioned responses.
authors: Department of Adult Mental Health, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan. kenichik@ncnp.go.jp
authors: Kenichi
authors: K
authors: Kuriyama
authors: Motoyasu
authors: M
authors: Honma
authors: Takahiro
authors: T
authors: Soshi
authors: Takeshi
authors: T
authors: Fujii
authors: Yoshiharu
authors: Y
authors: Kim
references: Clin Psychol Rev. 2008 Feb;28(2):199-210
references: 17532105
references: Neurobiol Learn Mem. 2011 May;95(4):505-9
references: 21402164
references: Learn Mem. 2008 Jan 03;15(1):39-45
references: 18174372
references: Learn Mem. 2004 Nov-Dec;11(6):727-31
references: 15537738
references: Learn Mem. 2007 Apr 06;14(4):268-76
references: 17522015
references: Biol Psychiatry. 2006 Aug 15;60(4):369-75
references: 16919524
references: Biol Psychiatry. 2007 Oct 15;62(8):835-8
references: 17588545
references: J Abnorm Psychol. 2000 May;109(2):290-8
references: 10895567
references: J Neurosci. 1996 May 1;16(9):3089-96
references: 8622138
references: Behav Neurosci. 2006 Oct;120(5):1159-62
references: 17014266
references: Arch Gen Psychiatry. 2006 Mar;63(3):298-304
references: 16520435
references: J Neurosci. 2006 Sep 27;26(39):10051-6
references: 17005868
references: Biol Psychol. 1978 Jun;6(4):301-8
references: 708814
references: Clin Pharmacol Ther. 1977 Jun;21(6):736-43
references: 324695
references: N Engl J Med. 2009 Jul 16;361(3):302-3
references: 19605837
references: Biol Psychiatry. 2008 Jun 15;63(12):1118-26
references: 18313643
references: Pharmacol Biochem Behav. 1982 Jul;17(1):49-52
references: 6812096
references: Am J Psychiatry. 2008 Mar;165(3):335-41; quiz 409
references: 18245177
references: Neurobiol Learn Mem. 2004 May;81(3):162-6
references: 15082017
references: Behav Neurosci. 2004 Jun;118(3):505-13
references: 15174928
references: J Psychiatr Res. 2007 Sep;41(6):466-71
references: 16828803
references: Eur J Pharmacol. 2006 Sep 18;545(2-3):142-6
references: 16884712
references: Biol Psychiatry. 2008 Mar 15;63(6):544-9
references: 18179785
references: Sleep. 1995 Jun;18(5):346-54
references: 7676168
references: Neuropharmacology. 2009 Feb;56(2):473-80
references: 19007798
references: Curr Drug Targets. 2001 Sep;2(3):273-83
references: 11554552
references: Behav Res Ther. 2007 Apr;45(4):663-72
references: 16962066
references: Neuropsychopharmacology. 2006 Feb;31(2):287-96
references: 16034442
references: Biol Psychiatry. 2010 Jun 15;67(12):1205-11
references: 20303474
references: Ann Hematol. 2004;83 Suppl 1:S91-2
references: 15124690
references: Biol Psychiatry. 2009 Oct 1;66(7):636-41
references: 19520359
references: Neuropharmacology. 1986 Jun;25(6):617-25
references: 3092125
references: Nat Neurosci. 2006 Jul;9(7):870-2
references: 16783370
references: Behav Neurosci. 2003 Apr;117(2):341-9
references: 12708530
references: Physiol Behav. 1979 Dec;23(6):1109-17
references: 542522
references: Am J Med. 1988 Jan 25;84(1A):7-13
references: 3146225
references: Antibiot Annu. 1955-1956;3:136-40
references: 13355257
references: Int Clin Psychopharmacol. 2007 Jul;22(4):230-7
references: 17519647
references: Pharmacology. 2009;84(6):356-66
references: 19907194
references: Arch Gen Psychiatry. 2004 Nov;61(11):1136-44
references: 15520361
references: Brain Res. 2008 Oct 27;1237:5-11
references: 18789905
references: Neurosci Lett. 2002 Aug 16;328(3):233-6
references: 12147314
references: J Neurosci. 2002 Mar 15;22(6):2343-51
references: 11896173
references: Biol Psychiatry. 2010 Dec 1;68(11):1073-6
references: 20817153
references: Sleep. 1996 Sep;19(7):563-9
references: 8899935
references: Cereb Cortex. 2009 Jan;19(1):187-96
references: 18477687
references: Biol Psychiatry. 2010 Feb 15;67(4):365-70
references: 19811776
references: Behav Res Ther. 2007 Sep;45(9):2002-18
references: 17451643
references: Hippocampus. 2001;11(5):529-42
references: 11732706